Home / Resource Library / Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study

Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study

Results of a study investigating CAR T lisocabtagene maraleucel for treatment of relapsed large b cell lymphomas.